ORX | Complete Orexo AB stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
kommenterade Orexo AB STOCKHOLM (Direkt) Orexo väntas presentera ett rörelseresultat på 18,3 miljoner kronor för årets tredje kvartal enligt en
7, Orexo AB, 415 766, 1.2%, 1.2%. ORX - Orexo AB Share Price · Momentum · Growth & Value · Margin of Safety · Qualifying GuruScreens · Quality · Financial Summary · Health Trend(F-Score). Get the latest Orexo AB (ORX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and View today's stock price, news and analysis for Orexo AB ADR (ORXOY). Barron's also provides information on historical stock ratings, target prices, company Get today's Orexo AB ADR stock price and latest ORXOY news as well as Orexo ADR real-time stock quotes, technical analysis, full financials and more. Orexo Ab ADR stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions.
Huvudmarknaden är den amerikanska marknaden för buprenorfin/naloxon produkter, där Orexo kommersialiserar huvudläkemedlet Zubsolv®, för behandling av opioidberoende. Huvudkontoret, där forskning och utvecklingsarbetet bedrivs, ligger i Uppsala. Total net sales for Orexo in 2020 amounted to SEK 664 million and the number of employees was 138. Orexo is listed on the Nasdaq Stockholm Mid Cap (ORX) and is available as ADRs on OTCQX (ORXOY) in the US. The company is headquartered in Uppsala, Sweden, … 2 Mkt Cap indicates the market value of the selected share series admitted to trading on Nasdaq Nordic. Note that the company may have other share series admitted to trading and that it may have unlisted shares. For complete information, please visit the company’s website. Total net sales for 2019 amounted to SEK 844,8 million and the number of employees was 127.
Moberg Pharma AB (publ) (MOB : STO) Stock Price & News; Medivir bab. 1) Orexo, 2) Medivir, 3) Active — P/e-tal = Aktiekurs / vinst per aktie.
Orexo is listed on the Nasdaq Stockholm Mid Cap (ORX) and is available as ADRs on OTCQX (ORXOY) in the US. The company is headquartered in Uppsala, Sweden, where research and development activities are performed. The Orexo AB PE ratio based on its reported earnings over the past 12 months is 56.38.The shares are currently trading at SEK51.9..
Orexos aktie är noterad på Nasdaq Stockholm Mid Cap (STO:ORX) och finns tillgänglig Denna information är sådan information som Orexo AB är skyldig att 2015-08-04, Orexo, ZUBSOLV® Market Access Update on Agreement with CVS
Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
Läs om våra viktigaste milstolpar sedan Orexo grundades i Uppsala 1995. Läs mer Kommuniké från Orexo AB:s årsstämma den 13 april 2021.
Körkort teori boka tid
Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
Improves lives for patients suffering from mental illness and substance use disorder 💚 | Orexo develops improved pharmaceuticals and digital
2021-03-31
Uppsala, Sweden – February 19, 2020 – Orexo AB (publ.), today invites investors, analysts and media to attend the company´s Capital Markets Day, taking place in
Global Streams UserStream • Reactions • PulseStream • SpecStream • EchoStream Stock Streams Message Board • SpecStream Trending • Trending Stocks • TV Buzz IPO Buzz (Pricings) • IPO Buzz (Upcoming) • Stocks Gapping Higher • Trending Public Companies (Top Volume Generators) Uplisted Stocks • New 52-Week Highs (NASDAQ) • New 52-Week Highs (NYSE) • New 52-Week Highs
2021-03-29 · Stock analysis for Orexo AB (ORX:Stockholm) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Market Cap: 1.558B: Beta (5Y Monthly) 0.63: PE Ratio (TTM) N/A: EPS (TTM)-2.45: Earnings Date: Apr 29, 2021: Forward Dividend & Yield: N/A (N/A) Ex-Dividend Date: N/A: 1y Target Est: 65.50
Market Capitalization Definition Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time.
Lidl tarife
deliberativ
leasa vs kopa bil
högertrafik 3 september 1967
ekelunds förlag läromedel
seth rogen
Orexo starts to test modia™ on patients in collaboration with ApexB.io and Magellan Rx Management. 10 February 2021 · Press Release. Orexo expects FDA filing of OX124 mid 2022. 29 January 2021 · …
UNCH. DATA AS OF Dec 21, 2020.
Sarasvathy what makes entrepreneurs entrepreneurial
at night i think of you
- Hur är det att jobba som fritidspedagog
- Resoribletter placeras
- No ämnen grundskolan
- Grundlarare fritidshem
2021-04-06
Orexo is listed on the Nasdaq Stockholm Mid Cap (ORX) and is available as ADRs on OTCQX (ORXOY) in the US. The company is headquartered in Uppsala, Sweden, where research and development activities are performed.
12 month transaction history compiled from ASX announcements. Date, Name, Bought, Previous %, New %. 15-12-20, Svenska Handelsbanken AB Publ
2021-04-06 ORXOY Market Cap as of today (March 13, 2021) is $180.37 Mil. In depth view into Orexo AB Market Cap explanation, calculation, historical data and more Name: Orexo AB (publ) Ticker: ORX; Exchange: OM; Founded: 1994; Industry: Pharmaceuticals; Sector: Pharmaceuticals & Biotech; Market Cap: kr1.532b; Shares outstanding: 34.29m; Website: https://www.orexo.com The P/Earnings NTM ratio of Orexo AB is significantly lower than the median of its peer group: around 15.00. The company valuation of Orexo AB according to these metrics is way below the market valuation of its peer group. The P/Earnings NTM ratio of Orexo AB is significantly lower than the average of its sector (Pharmaceuticals): 2.92. 2021-03-24 Orexo starts to test modia™ on patients in collaboration with ApexB.io and Magellan Rx Management. 10 February 2021 · Press Release.
Total net sales for 2018 amounted to SEK 783.1 million and the number of employees was 129.